id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-264646-d7qexyav	Raza, Syed Shadab	Mesenchymal Stem Cells: A new front emerge in COVID19 treatment: Mesenchymal Stem Cells therapy for SARS-CoV2 viral infection	2020-07-15		.txt	text/plain	2773	143	43	Currently, treating coronavirus disease 2019 (COVID19) patients, particularly those afflicted with severe pneumonia, is challenging, as no effective pharmacotherapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exists. Based on results from preliminary clinical investigations, one predicts that MSCs therapy for SARS-CoV-2 infected patients is safe and effective although multiple clinical trials with a protracted follow-up will be necessary to determine the long term effects of the treatment on COVID19 patients. Further, MSCs exhibit broad immune regulatory function, which makes them suitable for anti-viral therapy as safety and effectiveness of these cells have been documented in clinical trials of severe lung infections [9, 10, 11] . The first study was a case report [12] , in which a critically ill 65-year-old female with severe pneumonia, respiratory failure, moderate anemia, hypertension, and multiple organ failure received three infusions of umbilical cord MSCs (UCMSCs, 5X10 7 cells/infusion), three days apart.	./cache/cord-264646-d7qexyav.txt	./txt/cord-264646-d7qexyav.txt